Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for REVEFENACIN
- Fasting Bioavailability Study of Mylan's Revefenacin Inhalation Solution
- Phase 4 COPD and Suboptimal Inspiratory Flow Rate
- Revefenacin in Chinese Subjects With Moderate to Very Severe Chronic Obstructive Pulmonary Disease(COPD)
- Feasibility, Safety and Efficacy of Nebulized Long-Acting Bronchodilators (Formoterol and Revefenacin) vs. Short-Acting Bronchodilators (Albuterol and Ipratropium) in Hospitalized Patients With AECOPD
- Revefenacin in Acute Respiratory Insufficiency in COPD
- A 42-day Parallel Group Safety Study of Revefenacin and Formoterol, Administered in Sequence and as a Combination, in Participants With COPD
- Revefenacin Peak Inspiratory Flow Rate (PIFR) Study in COPD
- Effects of TD-4208 on FEV1 in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
- Thorough QT (TQT) Study of TD-4208 in Healthy Subjects
- TD-4208 Absorption, Distribution, Metabolism and Excretion (ADME) Study in Healthy Male Subjects
- Pharmacokinetics of TD-4208 in Patients With Moderate Hepatic Impairment
- Pharmacokinetics of TD-4208 in Patients With Severe Renal Impairment
- A 52-Week Parallel Group Safety Study of TD-4208 in Chronic Obstructive Pulmonary Disease (COPD)
- Efficacy Study of Nebulized TD-4208 for Chronic Obstructive Pulmonary Disease (COPD)
- Efficacy Study of Nebulized TD-4208 for Chronic Obstructive Pulmonary Disease (COPD)
- A 7-Day Cross-over Study of QD (Once Daily) and BID (Twice Daily) TD-4208 in Chronic Obstructive Pulmonary Disease (COPD)
- A 28-Day Parallel Group Study of TD-4208 in Chronic Obstructive Pulmonary Disease (COPD)
- 7 Days of TD-4208 in Subjects With Chronic Obstructive Pulmonary Disease
Clinical trials list
click for details